Chemotherapy, Alopecia, and Scalp Cooling Systems
Actas Dermosifiliogr. 2022 Mar;113(3):278-283.
doi: 10.1016/j.ad.2021.09.003.
Epub 2021 Oct 12.
[Article in
English,
Spanish]
Affiliations
- 1 Servicio de Oncología Clínica, Hospital de Clínicas, Facultad de Medicina, Universidad de La República, Montevideo, Uruguay; Departamento Básico de Medicina, Hospital de Clínicas, Facultad de Medicina, Universidad de La República, Montevideo, Uruguay. Electronic address: damarillo@hc.edu.uy.
- 2 Instituto Nacional del Cáncer, Montevideo, Uruguay, Unidad de Oncología Cutánea, Servicio de Oncología Clínica, Hospital de Clínicas, Facultad de Medicina, Universidad de La República, Montevideo, Uruguay.
- 3 Servicio de Oncología Clínica, Hospital de Clínicas, Facultad de Medicina, Universidad de La República, Montevideo, Uruguay.
Abstract
Chemotherapy-induced hair loss in cancer is usually temporary but can take a significant emotional toll on patients and lead to treatment refusal in many cases. Although hair loss is usually reversible, regrowth can take months, causing greater psychological distress. Recent years have seen the emergence of cold caps, or scalp cooling systems, designed to prevent or at least reduce chemotherapy-induced hair loss. The results to date are encouraging. We review the evidence on the effects and effectiveness of these systems, which are making their way into routine clinical practice.
Keywords:
Alopecia; Chemotherapy; Cold caps; Gorros fríos; Quimioterapia; Scalp cooling systems; Uso de gorras de frío.
Copyright © 2021 AEDV. Publicado por Elsevier España, S.L.U. All rights reserved.
MeSH terms
-
Alopecia / chemically induced
-
Alopecia / prevention & control
-
Antineoplastic Agents* / adverse effects
-
Antineoplastic Combined Chemotherapy Protocols / therapeutic use
-
Breast Neoplasms* / drug therapy
-
Female
-
Humans
-
Hypothermia, Induced* / methods
-
Prospective Studies
-
Scalp